Symposia

Below is the list of symposia confirmed to date for T21RS 2026.

  • Brain Development and Connectivity Across the Lifespan in Down Syndrome: Insights from Cellular Mechanisms, Mouse Models, and Advanced Human MRI.
  • Eating, drinking, and swallowing challenges in Down syndrome: From clinical perspectives to insights from animal models
  • The DS-Connect® Registry and the INCLUDE Collaboration for Down Syndrome Progress (CDP): Two Transformative Tools to Accelerate Participant-Centered Research
  • Microbiome insights in Down Syndrome
  • Executive Function in Down Syndrome Across the Lifespan: From Mechanisms to Modifiers of Alzheimer’s Disease Risk
  • Innovative Engagement Methods and Communication Strategies for Promoting Down Syndrome Clinical Research Participation
  • Lifelong bone health in Down syndrome: new research, new directions
  • Immune dysregulation in people with Down syndrome: From mechanisms to clinical trials
  • Effective community engagement in older adults with Down syndrome: The ABC-DS experience
  • Metabolic dysfunction and associated liver abnormalities in individuals with Down syndrome
  • Hearing and Vestibular Sequelae in Down Syndrome
  • Update on blood pressure regulation in Down syndrome – is it truly protective?
  • Down Syndrome Regression Disorder: New Frontiers in Biomarkers, Phenotypes, and Clinical Trials
  • Advancing Knowledge on lifestyle factors in the context of Gene Overdosage and Early-Life Obesity in Down Syndrome, the legacy of GO-DS21.
  • Aging and Down syndrome
  • Unraveling Risk and Resilience: The Role of Co-Occurring Health Conditions in Down Syndrome-Associated Alzheimer’s Disease
  • Transforming health outcomes for Down syndrome using Population Level Data
  • Research advances toward the treatment of obstructive sleep apnea in people with Down syndrome
  • Amyloid-lowering Immunotherapies for Down Syndrome-related Alzheimer’s disease: Neuropathological Insights and Vascular Safety in Clinical Trials
  • The INCLUDE Data Coordinating Center: a discovery accelerator for Down syndrome research